Search Results Search Sort by RelevanceMost Recent State of the Art and Science Jan 2021 “Prevention” and Human Gene Editing Governance Eric T. Juengst, PhD The Holocaust and the racial hygiene doctrine that helped rationalize it still overshadow contemporary debates about using gene editing for disease prevention. AMA J Ethics. 2021;23(1):E49-54. doi: 10.1001/amajethics.2021.49. Viewpoint Dec 2019 Genome Editing, Ethics, and Politics Isabel Gabel, PhD and Jonathan Moreno, PhD Genome editing raises old questions, but CRISPR arose in a political landscape that vastly differs from the early aughts. AMA J Ethics. 2019;21(12):E1105-1110. doi: 10.1001/amajethics.2019.1105. Podcast Dec 2019 Ethics Talk: How Do We Prepare for Human Gene Editing? Dr Sean C. McConnell provides an introduction to gene editing, and Scott J. Schweikart discusses what prudent governance requires. Case and Commentary Feb 2020 How Should Physicians in Low- and Middle-Income Countries Regard Electronic Nicotine Delivery Systems to Facilitate Smoking Cessation? Thomas E. Novotny, MD, MPH, DSc (Hon) and May C. I. van Schalkwyk, MBBS, MPH Vaping has been thought to be a safe, effective smoking cessation aid, but little evidence supports its value in mitigating tobacco use. AMA J Ethics. 2020;22(2):E82-92. doi: 10.1001/amajethics.2020.82. Case and Commentary Jan 2005 Mrs. Douglas's Choice of Treatment for Her Husband, Option Comparison Jennifer Reenan, MD Virtual Mentor. 2005;7(1):-. doi: 10.1001/virtualmentor.2005.7.1.ccas7c-0501. Case and Commentary Aug 2006 Prescribing a Teratogenic Medication Jeffrey M. Weinberg, MD Virtual Mentor. 2006;8(8):495-498. doi: 10.1001/virtualmentor.2006.8.8.ccas3-0608. Health Law Dec 2016 The Legal Implications of Detecting Alzheimer’s Disease Earlier Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, and Francis X. Shen, JD, PhD What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early? AMA J Ethics. 2016;18(12):1207-1217. doi: 10.1001/journalofethics.2016.18.12.hlaw1-1612. Case and Commentary Jan 2007 Helping Patients Decide Whether to Participate in Clinical Trials Martin L. Smith, STD and Eric D. Kodish, MD Virtual Mentor. 2007;9(1):16-20. doi: 10.1001/virtualmentor.2007.9.1.ccas3-0701. Case and Commentary Sep 2007 Pregnant Women and Cervical Cancer: Balancing Best Interest of Mother and Fetus Watson A. Bowes, Jr., MD Virtual Mentor. 2007;9(9):600-604. doi: 10.1001/virtualmentor.2007.9.9.ccas1-0709. In the Literature Jun 2008 Managing Difficult Behaviors in Patients with Dementia Richard Hwang Virtual Mentor. 2008;10(6):379-382. doi: 10.1001/virtualmentor.2008.10.6.disc1-0806. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Next page Next › Last page Last »
State of the Art and Science Jan 2021 “Prevention” and Human Gene Editing Governance Eric T. Juengst, PhD The Holocaust and the racial hygiene doctrine that helped rationalize it still overshadow contemporary debates about using gene editing for disease prevention. AMA J Ethics. 2021;23(1):E49-54. doi: 10.1001/amajethics.2021.49.
Viewpoint Dec 2019 Genome Editing, Ethics, and Politics Isabel Gabel, PhD and Jonathan Moreno, PhD Genome editing raises old questions, but CRISPR arose in a political landscape that vastly differs from the early aughts. AMA J Ethics. 2019;21(12):E1105-1110. doi: 10.1001/amajethics.2019.1105.
Podcast Dec 2019 Ethics Talk: How Do We Prepare for Human Gene Editing? Dr Sean C. McConnell provides an introduction to gene editing, and Scott J. Schweikart discusses what prudent governance requires.
Case and Commentary Feb 2020 How Should Physicians in Low- and Middle-Income Countries Regard Electronic Nicotine Delivery Systems to Facilitate Smoking Cessation? Thomas E. Novotny, MD, MPH, DSc (Hon) and May C. I. van Schalkwyk, MBBS, MPH Vaping has been thought to be a safe, effective smoking cessation aid, but little evidence supports its value in mitigating tobacco use. AMA J Ethics. 2020;22(2):E82-92. doi: 10.1001/amajethics.2020.82.
Case and Commentary Jan 2005 Mrs. Douglas's Choice of Treatment for Her Husband, Option Comparison Jennifer Reenan, MD Virtual Mentor. 2005;7(1):-. doi: 10.1001/virtualmentor.2005.7.1.ccas7c-0501.
Case and Commentary Aug 2006 Prescribing a Teratogenic Medication Jeffrey M. Weinberg, MD Virtual Mentor. 2006;8(8):495-498. doi: 10.1001/virtualmentor.2006.8.8.ccas3-0608.
Health Law Dec 2016 The Legal Implications of Detecting Alzheimer’s Disease Earlier Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, and Francis X. Shen, JD, PhD What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early? AMA J Ethics. 2016;18(12):1207-1217. doi: 10.1001/journalofethics.2016.18.12.hlaw1-1612.
Case and Commentary Jan 2007 Helping Patients Decide Whether to Participate in Clinical Trials Martin L. Smith, STD and Eric D. Kodish, MD Virtual Mentor. 2007;9(1):16-20. doi: 10.1001/virtualmentor.2007.9.1.ccas3-0701.
Case and Commentary Sep 2007 Pregnant Women and Cervical Cancer: Balancing Best Interest of Mother and Fetus Watson A. Bowes, Jr., MD Virtual Mentor. 2007;9(9):600-604. doi: 10.1001/virtualmentor.2007.9.9.ccas1-0709.
In the Literature Jun 2008 Managing Difficult Behaviors in Patients with Dementia Richard Hwang Virtual Mentor. 2008;10(6):379-382. doi: 10.1001/virtualmentor.2008.10.6.disc1-0806.